Resonance Health Ltd (RHT) - Total Liabilities
Based on the latest financial reports, Resonance Health Ltd (RHT) has total liabilities worth AU$7.02 Million AUD (≈ $4.97 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore RHT net asset momentum to track the company's year-over-year net asset growth rate.
Resonance Health Ltd - Total Liabilities Trend (1989–2025)
This chart illustrates how Resonance Health Ltd's total liabilities have evolved over time, based on quarterly financial data. See RHT free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Resonance Health Ltd Competitors by Total Liabilities
The table below lists competitors of Resonance Health Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ClearSign Combustion Corporation
NASDAQ:CLIR
|
USA | $2.65 Million |
|
Hansol Homedec
KO:025750
|
Korea | ₩128.30 Billion |
|
ARENA.PL S.A. ZY -50
F:8G6
|
Germany | €609.11K |
|
RIAS A/S
CO:RIAS-B
|
Denmark | Dkr56.97 Million |
|
Nortech Systems Incorporated
NASDAQ:NSYS
|
USA | $41.40 Million |
|
Inter Rock Minerals Inc
V:IRO
|
Canada | CA$16.51 Million |
|
Passat Société Anonyme
PA:ALXIL
|
USA | €38.68 Million |
|
ANGLER GAMING PLC EO -01
F:0QM
|
Germany | €4.17 Million |
Liability Composition Analysis (1989–2025)
This chart breaks down Resonance Health Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see RHT market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.87 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.77 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.64 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.39 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Resonance Health Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Resonance Health Ltd (1989–2025)
The table below shows the annual total liabilities of Resonance Health Ltd from 1989 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$8.50 Million ≈ $6.01 Million |
-9.12% |
| 2024-06-30 | AU$9.35 Million ≈ $6.62 Million |
+792.37% |
| 2023-06-30 | AU$1.05 Million ≈ $741.47K |
+5.26% |
| 2022-06-30 | AU$995.58K ≈ $704.43K |
+62.75% |
| 2021-06-30 | AU$611.74K ≈ $432.84K |
+3.50% |
| 2020-06-30 | AU$591.04K ≈ $418.20K |
+13.00% |
| 2019-06-30 | AU$523.06K ≈ $370.10K |
-5.19% |
| 2018-06-30 | AU$551.67K ≈ $390.34K |
-37.61% |
| 2017-06-30 | AU$884.21K ≈ $625.63K |
-0.97% |
| 2016-06-30 | AU$892.90K ≈ $631.78K |
+13.43% |
| 2015-06-30 | AU$787.16K ≈ $556.97K |
-16.07% |
| 2014-06-30 | AU$937.85K ≈ $663.59K |
+12.49% |
| 2013-06-30 | AU$833.75K ≈ $589.93K |
+5.80% |
| 2012-06-30 | AU$788.05K ≈ $557.60K |
+35.97% |
| 2011-06-30 | AU$579.58K ≈ $410.09K |
+11.35% |
| 2010-06-30 | AU$520.49K ≈ $368.28K |
+34.60% |
| 2009-06-30 | AU$386.69K ≈ $273.61K |
+52.65% |
| 2008-06-30 | AU$253.32K ≈ $179.24K |
-41.55% |
| 2007-06-30 | AU$433.41K ≈ $306.67K |
+1.23% |
| 2006-06-30 | AU$428.15K ≈ $302.94K |
+5.52% |
| 2005-06-30 | AU$405.75K ≈ $287.10K |
+54.36% |
| 2004-06-30 | AU$262.87K ≈ $186.00K |
+795.75% |
| 2003-06-30 | AU$29.35K ≈ $20.76K |
-99.64% |
| 2002-06-30 | AU$8.21 Million ≈ $5.81 Million |
-38.76% |
| 2000-06-30 | AU$13.41 Million ≈ $9.49 Million |
+742.61% |
| 1999-06-30 | AU$1.59 Million ≈ $1.13 Million |
-90.25% |
| 1998-06-30 | AU$16.32 Million ≈ $11.55 Million |
+10.94% |
| 1997-06-30 | AU$14.71 Million ≈ $10.41 Million |
+8.51% |
| 1996-06-30 | AU$13.56 Million ≈ $9.59 Million |
+479.90% |
| 1995-06-30 | AU$2.34 Million ≈ $1.65 Million |
+1267.25% |
| 1994-06-30 | AU$171.00K ≈ $120.99K |
+119.23% |
| 1993-06-30 | AU$78.00K ≈ $55.19K |
+254.55% |
| 1992-06-30 | AU$22.00K ≈ $15.57K |
+57.14% |
| 1991-06-30 | AU$14.00K ≈ $9.91K |
-33.33% |
| 1990-06-30 | AU$21.00K ≈ $14.86K |
-89.12% |
| 1989-06-30 | AU$193.00K ≈ $136.56K |
-- |
About Resonance Health Ltd
Resonance Health Limited, a healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices (SaMD) in the Asia Pacific, North America, Europe, the Middle East, and Africa. It operates through SaMD, Resonance Clinical, and TrialsWest segments. The company offers FerriScan, a non-invasive MRI based solution for quantifying liver iron conce… Read more